Ablation for Recurrent Hepatocellular Carcinoma: A Systematic Review of Clinical Efficacy and Prognostic Factors

Background Hepatocellular carcinoma (HCC) typically recurs following primary treatment. The primary objective of this systematic review was to evaluate the safety and efficacy of ablative therapies for recurrent HCC. The secondary objective was to identify any factors associated with prognosis following ablation for recurrent disease.